Mohamed H. Shahin
Pfizer (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Hormonal Regulation and Hypertension, Metabolomics and Mass Spectrometry Studies, Statistical Methods in Clinical Trials, Machine Learning in Healthcare
Most-Cited Works
- → Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study(2013)274 cited
- → Genetic and nongenetic factors associated with warfarin doserequirements in Egyptian patients(2011)101 cited
- → Impact of the CYP4F2 p.V433M Polymorphism on Coumarin Dose Requirement: Systematic Review and Meta-Analysis(2012)68 cited
- → Artificial Intelligence for Quantitative Modeling in Drug Discovery and Development: An Innovation and Quality Consortium Perspective on Use Cases and Best Practices(2023)63 cited
- → Association of Branched and Aromatic Amino Acids Levels with Metabolic Syndrome and Impaired Fasting Glucose in Hypertensive Patients(2015)36 cited
- → VKORC1 Asp36Tyr geographic distribution and its impact on warfarin dose requirements in Egyptians(2013)32 cited
- → Effect of CYP 4F2 , VKORC 1 , and CYP 2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals(2018)32 cited
- → Open Data Revolution in Clinical Research: Opportunities and Challenges(2020)32 cited
- → Artificial Intelligence: From Buzzword to Useful Tool in Clinical Pharmacology(2023)29 cited
- → A Genetic Response Score for Hydrochlorothiazide Use(2016)27 cited